BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 668199)

  • 1. Treatment of Goodpasture's disease by plasma exchange and immunosuppression.
    Swainson CP; Robson JS; Urbaniak SJ; Keller AJ; Kay AB
    Clin Exp Immunol; 1978 May; 32(2):233-42. PubMed ID: 668199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of plasma exchange and immunosuppression to improve renal function in Goodpasture's syndrome.
    McLeish KR; Maxwell DR; Luft FC
    Clin Nephrol; 1978 Aug; 10(2):71-3. PubMed ID: 699402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and morphological aspects of the management of crescentic anti-glomerular basement membrane antibody (anti-GBM) nephritis/Goodpasture's syndrome.
    Walker RG; Scheinkestel C; Becker GJ; Owen JE; Dowling JP; Kincaid-Smith P
    Q J Med; 1985 Jan; 54(213):75-89. PubMed ID: 3975346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence of circulating anti-glomerular basement membrane antibody three years after immunosuppressive treatment and plasma exchange.
    Hind CR; Bowman C; Winearls CG; Lockwood CM
    Clin Nephrol; 1984 Apr; 21(4):244-6. PubMed ID: 6733989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case report of efficiency of double filtration plasmapheresis in treatment of Goodpasture's syndrome.
    Hajime N; Michiko A; Atsunori K; Tatsuo K; Yuko N; Naoki O; Katsuhiko S
    Ther Apher Dial; 2009 Aug; 13(4):373-7. PubMed ID: 19695077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation, immunosuppression and plasmapheresis in Goodpasture's syndrome.
    Cove-Smith JR; McLeod AA; Blamey RW; Knapp MS; Reeves WG; Wilson CB
    Clin Nephrol; 1978 Mar; 9(3):126-8. PubMed ID: 346273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoadsorption in Goodpasture's syndrome.
    Laczika K; Knapp S; Derfler K; Soleiman A; Hörl WH; Druml W
    Am J Kidney Dis; 2000 Aug; 36(2):392-5. PubMed ID: 10922318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Goodpasture's syndrome with asymptomatic renal involvement. Disappearance of antiglomerular basement membrane antibodies deposits after treatment.
    Lamriben L; Kourilsky O; Mougenot B; Ronco P; Sraer JD
    Nephrol Dial Transplant; 1993; 8(11):1267-9. PubMed ID: 8302468
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome.
    Lockwood CM; Rees AJ; Pearson TA; Evans DJ; Peters DK; Wilson CB
    Lancet; 1976 Apr; 1(7962):711-5. PubMed ID: 56532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of resistant Goodpasture's syndrome and staghorn calculus--treatment with bilateral nephrectomy.
    Pai P; Kumar S; Bell GM
    Clin Nephrol; 1996 Jul; 46(1):10-2. PubMed ID: 8832142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane.
    Lindic J; Vizjak A; Ferluga D; Kovac D; Ales A; Kveder R; Ponikvar R; Bren A
    Ther Apher Dial; 2009 Aug; 13(4):278-81. PubMed ID: 19695059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [79-year-old patient with pulmorenal syndrome].
    Artunc F; Dorn C; Gehlen F; Büttner M; Amann K; Weyrich P; Heyne N; Wolf S
    Dtsch Med Wochenschr; 2010 Oct; 135(40):1982. PubMed ID: 20922641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Goodpasture's syndrome--effects of plasmapheresis.
    Munk ZM; Skamene E
    Clin Exp Immunol; 1979 May; 36(2):244-9. PubMed ID: 477027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of kidney-bound antibodies in Goodpasture's syndrome.
    Saxena R; Bygren P; Butkowski R; Wieslander J
    Clin Exp Immunol; 1989 Oct; 78(1):31-6. PubMed ID: 2805421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staphylococcal protein A immunoadsorption for Goodpasture's syndrome in four Chinese patients.
    Hu W; Liu Z; Ji D; Xie H; Gong D; Li L
    J Nephrol; 2006; 19(3):312-7. PubMed ID: 16874690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Goodpasture's syndrome: haemodialysis, pacing and extrapulmonary oxygenation.
    Löcsey L; Kakuk G; Wórum I; Wórum F; Szabó J; Kovács P; Gyarmati J
    Acta Med Acad Sci Hung; 1980; 37(3):289-98. PubMed ID: 7457031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and outcomes of patients with Goodpasture's syndrome.
    Shah MK; Hugghins SY
    South Med J; 2002 Dec; 95(12):1411-8. PubMed ID: 12597309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of combined plasmapheresis and immunosuppression in the treatment of Goodpasture's syndrome.
    Erickson SB; Kurtz SB; Donadio JV; Holley KE; Wilson CB; Pineda AA
    Mayo Clin Proc; 1979 Nov; 54(11):714-20. PubMed ID: 491763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-basement-membrane antibody mediated, rapidly progressive, glomerulonephritis. Diagnostic and therapeutic strategy based on a retrospective study of 14 cases].
    Bouget J; Le Pogamp P; Perrier G; Ramée MP; Rivalan J; Camus C; Thomas R; Chevet D
    Ann Med Interne (Paris); 1990; 141(5):409-15. PubMed ID: 2256583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma exchange in Goodpasture's syndrome.
    Simpson IJ; Doak PB; Williams LC; Blacklock HA; Hill RS; Teague CA; Herdson PB; Wilson CB
    Am J Nephrol; 1982; 2(6):301-11. PubMed ID: 6762091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.